Welcome to IthaMaps

IthaMaps is a global epidemiology database of heamoglobinopathies, illustrating published data on a dynamic global to regional map. Country-specific information on haemoglobinopathy-related policies, prevalence, incidence and overall disease burden is given, including relative allele frequencies of specific globin mutations in each country and/or region, dynamically linked to corresponding IthaGenes entries.

IthaMaps content was supported by partnership with the HVP Global Globin 2020 Challenge

Search

Search Country: OR Search for:  Show organisations

  General information for Ghana


Ghana
Continent: Africa
Capital: Accra
Population: 24339838
Area (in sq km): 239460.0

Haemoglobinopathy-specific healthcare policy information for Ghana

Healthcare policyComment/InfoReference
Prevention programme: NoPremarital testing as part of marriage counselling sessions by religious organisations.[PMID: 30171429]
SCD newborn screening: Yes (National)Started in 1993 as a pilot/research programme and scaled to a national programme in 2010 by the Government of Ghana. Heel prick test performed at 40 facilities in Kumasi and Accra plus two rural sites. There is also linkage to reproductive, maternal, newborn and child health (RMNCH) programmes [AFR/RC70/INF.DOC/3; 30July2020]. [PMID: 32415570]
Prenatal screening: No[PMID: 30171429]
Haemoglobinopathies patient registry: No Part of a multi-country sickle cell disease registry (SickleInAfrica registry).[PMID: 31649726]
Rare disease patient registry: NoPlanned under the Rare Disease Ghana Initiative
Dedicated treatment centres: Yes (National)From: PGPR, Global Sickle Cell Disease Network.
Blood transfusion availability: Yes (National)From: PGPR, Global Sickle Cell Disease Network.
MRI facilities: Yes (National)From: PGPR, Global Sickle Cell Disease Network.
Patient associations: Yes (National)E.g.: The Sickle Cell Foundation of Ghana (SCFG), inaugurated in 2004.[PMID: 27090687]
Genetic counselling: Yes (National)The NBS programme has established a SCD genetic counseling training and certification programme for health workers, called GENECIS-Ghana.[PMID: 32415570]

  Prevalence and incidence of major haemoglobinopathies in Ghana

HaemoglobinopathyComment/InfoReference
Prevalence of β-thalassaemia carriers: 1.5 % of the populationRanges between 1-11%. From: Bain, Barbara J., Haemoglobinopathy Diagnosis, 2nd edition.
Prevalence of sickle cell disease carriers: 13.3 % of the population[PMID: 26633548]
Prevalence of Hb C carriers: 10.5 % of the population[PMID: 20231425]
Incidence of sickle cell disease: 5474 affected births/yearMedian value estimated using statistical model and demographic data.[PMID: 23103089]

  Global Burden of Disease data for Ghana

  Migration data for Ghana

Mutation frequencies in Ghana

No mutation frequencies are currently available for Ghana

  Organisations in Ghana

Organisations in Ghana are currently not available

 Microattributions

A/AContributor(s)DateComments
1Elion, Jacques2017-10-17Information on SCD newborn screening reviewed.

To provide new epidemiological information and/or report mistakes, please register/log in first or use the Contact Us form.

Important Note: The relative allele frequencies presented in IthaMaps are not calculated by ITHANET, but they are extracted from the corresponding publications. ITHANET is not responsible for any mistakes in the data. Please use this information with caution! We encourage scientists that have more detailed or updated epidemiological information to contact us.

Disclaimer: The information on this website is provided as an information resource only and must not to be used as a substitute for professional diagnosis and treatment. The ITHANET Portal and IthaMaps are not responsible or liable for any advice, course of treatment, diagnosis or any other information, services or products that an individual obtains through this website.